MARINUS PHARMACEUTICALS INC (39)

Browse by Contract Category

Contracts

Form of Pre-funded Warrant to Purchase Common Stock (Filed With SEC on November 10, 2022)
Amendment No. 2, dated September 21, 2022, by and between Marinus Pharmaceuticals, Inc. and the Biomedical Advanced Research and Development Authority, a division of the U.S.... (Filed With SEC on September 23, 2022)
Form of Restricted Stock Unit Agreement containing a Sell to Cover Election for Employees granted as an Inducement Award, under the Marinus Pharmaceuticals, Inc. 2014 Equity... (Filed With SEC on March 24, 2022)
Description of the Registrants Securities (Filed With SEC on March 24, 2022)
License Agreement, dated March 1, 2022, by and between Marinus Pharmaceuticals, Inc. and Ovid Therapeutics Inc (Filed With SEC on March 3, 2022)
Underwriting Agreement, dated November 7, 2022, by and among Marinus Pharmaceuticals, Inc., SVB Securities LLC, RBC Capital Markets, LLC and Cantor Fitzgerald & Co (Filed With SEC on November 10, 2022)
Limited Consent and First Amendment to Credit Agreement, dated October 28, 2022, by and among Marinus Pharmaceuticals, Inc., as Grantor, and Oaktree Fund Administration, LLC, as... (Filed With SEC on November 7, 2022)
Security Agreement dated October 28, 2022, by and among Marinus Pharmaceuticals, Inc. and Sagard Healthcare Royalty Partners, LP (Filed With SEC on November 7, 2022)
Revenue Interest Financing Agreement, dated October 28, 2022, by and between Marinus Pharmaceuticals, Inc. and Sagard Healthcare Royalty Partners, LP (Filed With SEC on November 7, 2022)
Asset Purchase Agreement, dated July 13, 2022, by and between Marinus Pharmaceuticals, Inc. and Novo Nordisk Inc (Filed With SEC on July 14, 2022)
Letter Agreement re: Amendment to Tranche C Commitment, dated May 23, 2022, by and among Marinus Pharmaceuticals, Inc., as Borrower, Oaktree Fund Administration, LLC, as... (Filed With SEC on May 25, 2022)
Amendment, dated March 29, 2022, by and between Marinus Pharmaceuticals, Inc. and the Biomedical Advanced Research and Development Authority, a division of the U.S. Department of... (Filed With SEC on March 31, 2022)
Form of Restricted Stock Unit Agreement for Employees granted as an Inducement Award, under the Marinus Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended (Filed With SEC on March 24, 2022)
Form of Restricted Stock Unit Agreement containing a Sell to Cover Election for Employees under the Marinus Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended (Filed With SEC on March 24, 2022)
Form of Amended and Restated Indemnification Agreement (Non-VC Directors) (Filed With SEC on March 24, 2022)
Form of Nonqualified Stock Option Agreement for Non-Employee Directors under the Marinus Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended (Filed With SEC on November 9, 2021)
Form of Restricted Stock Unit Agreement for Non-Employee Directors under the Marinus Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended (Filed With SEC on November 9, 2021)
Form of Restricted Stock Unit Agreement for Employees under the Marinus Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended (Filed With SEC on November 9, 2021)
Form of Nonqualified Stock Option Agreement for Employees granted as an Inducement Award (Filed With SEC on November 9, 2021)
Form of Nonqualified Stock Option Agreement for Employees under the Marinus Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended (Filed With SEC on November 9, 2021)
Collaboration Agreement, dated as of July 30, 2021, by and between Marinus Pharmaceuticals, Inc. and Orion Corporation (Filed With SEC on November 9, 2021)
Form of Incentive Stock Option Agreement for Employees under the Marinus Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended (Filed With SEC on November 9, 2021)
First Amendment to Executive Employment Agreement, by and between Marinus Pharmaceuticals, Inc. and Steven Pfanstiel, MBA, CMA dated April 9, 2021 (Filed With SEC on April 13, 2021)
Employment Agreement dated as of June 15, 2020 between the Company and Martha Manning (Filed With SEC on March 9, 2021)
Form of Amended and Restated Indemnification Agreement (Non-VC Directors) (Filed With SEC on March 9, 2021)
Employment Agreement, effective as of April 12, 2021, between the Company and Steven Pfanstiel (Filed With SEC on March 9, 2021)
Separation and Consulting Agreement and General Release, dated as of March 9, 2021, between the Company and Edward F. Smith (Filed With SEC on March 9, 2021)
Description of the Registrants Securities (Filed With SEC on March 9, 2021)
Underwriting Agreement, dated December 8, 2020, by and between Marinus Pharmaceuticals, Inc. and Cantor Fitzgerald & Co (Filed With SEC on December 9, 2020)
Marinus Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended (Filed With SEC on November 9, 2020)
Underwriting Agreement, dated May 28, 2020, by and among Marinus Pharmaceuticals, Inc., Cowen and Company, LLC and Cantor Fitzgerald & Co (Filed With SEC on May 29, 2020)
Form of Amended and Restated Indemnification Agreement (Non-VC Directors) (Filed With SEC on March 16, 2020)
Description of the Registrants Securities (Filed With SEC on March 16, 2020)
Securities Purchase Agreement dated December 11, 2019 between the Company and the Investors listed therein (Filed With SEC on December 13, 2019)
Underwriting Agreement dated December 11, 2019 (Filed With SEC on December 13, 2019)
Employment Agreement dated as of October 25, 2019 between Joe Hulihan, M.D. and Marinus Pharmaceuticals, Inc (Filed With SEC on October 29, 2019)
Marinus Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended, effective as of May 7, 2019 (Filed With SEC on August 8, 2019)
Amended and Restated Employment Agreement dated as of August 6, 2019, between the Company and Scott Braunstein, M.D (Filed With SEC on August 8, 2019)
Employment Agreement dated as of February 26, 2019 between the Company and Scott Braunstein (Filed With SEC on March 12, 2019)